Watch These Today: PCTEL (NASDAQ:PCTI), JA Solar Holdings Co., (NASDAQ:JASO), ZIOPHARM Oncology (NASDAQ:ZIOP), Apricus Biosciences (NASDAQ:APRI)

Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) shares fell -0.20% in last trading session and ended the day at $75.55. QIHU Gross Margin is 77.20% and its has a return on assets of 8.00%. Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) quarterly performance is 3.73%.

Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) announced that it has called an extraordinary general meeting of shareholders (the “EGM”), to be held on March 30, 2016 at 10:00 a.m. (Beijing time), at 3/F, Building #2, 6 Jiuxianqiao Road, Chaoyang District, Beijing

PCTEL, Inc. (NASDAQ:PCTI) ended the last trading day at $4.78. Company weekly volatility is calculated as 8.19% and price to cash ratio as 2.59. PCTEL, Inc. (NASDAQ:PCTI) showed a weekly performance of 1.49%.

PCTEL, Inc. (NASDAQ:PCTI) announced the launch of its SkyCompass™ Trooper multiband antennas today at the International Wireless Communications Expo (IWCE). The new platform delivers exceptional RF performance for voice, data, and asset tracking applications in an ultra-compact footprint. The SkyCompass Trooper will equip the next generation of public safety fleets with high-speed, interoperable wireless communications.

JA Solar Holdings Co., Ltd. (NASDAQ:JASO) caters to the Technology space. It has a net profit margin of 4.70% and weekly performance is -1.37%. On the last day of trading company shares ended up at $8.61. JA Solar Holdings Co., Ltd. (NASDAQ:JASO) distance from 50-day simple moving average (SMA50) is 7.53%.

On 15 March, JA Solar Holdings Co., Ltd. (NASDAQ:JASO) announced its unaudited financial results for its fourth quarter and fiscal year ended December 31, 2015. Shipments of modules and module tolling were 1,297.6 MW, increases of +47.5% y/y and +20.8% sequentially

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) shares advanced 2.34% in last trading session and ended the day at $7.42. ZIOP has a return on assets of -82.40%. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) quarterly performance is -10.92%.

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies 2nd Annual Immuno-Oncology Summit on Thursday, April 7th, 2016 at 9:35 a.m. ET. The conference is being held at the Boston Harbor Hotel in Boston, MA.

Apricus Biosciences, Inc. (NASDAQ:APRI) caters to the Healthcare space. Its weekly performance is -51.58%. On the last day of trading company shares ended up at $0.58. Apricus Biosciences, Inc. (NASDAQ:APRI) distance from 50-day simple moving average (SMA50) is 18.84%.

Zacks Investment Research upgraded shares of Apricus Biosciences Inc (NASDAQ:APRI) from a hold rating to a buy rating in a research report published on Friday morning, MarketBeat.com reports. They currently have $1.25 price target on the stock.